Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
Merck
Chubb
Farmers Insurance
Covington
Chinese Patent Office
Healthtrust
US Army

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017579

« Back to Dashboard

NDA 017579 describes RETIN-A, which is a drug marketed by Valeant Bermuda, Valeant Pharms North, and Valeant Intl, and is included in seven NDAs. It is available from five suppliers. Additional details are available on the RETIN-A profile page.

The generic ingredient in RETIN-A is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 017579
Tradename:RETIN-A
Applicant:Valeant Intl
Ingredient:tretinoin
Patents:0
Therapeutic Class:Antineoplastics
Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017579
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 017579
Suppliers and Packaging for NDA: 017579
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RETIN-A tretinoin GEL;TOPICAL 017579 NDA Valeant Pharmaceuticals North America LLC 0187-5170 N 0187-5170-15
RETIN-A tretinoin GEL;TOPICAL 017579 NDA Valeant Pharmaceuticals North America LLC 0187-5170 N 0187-5170-45

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017579

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017579-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017579-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
McKesson
Cerilliant
Dow
Covington
McKinsey
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.